Why weight loss is not the end of the treatment pathway During active GLP-1 treatment, many people experience reduced appetite, fewer food thoughts, and greater control over eating
A 2020 study of "wellness" B12 injections in non-deficient adults found no improvement in energy, mood, or cognitive function versus placebo at 4 weeks (Wolffenbuttel et al., Nutrients , 2020)
Ozempic and Weight Loss Ozempic (semaglutide) is FDA-approved to help control blood sugar levels in people with type 2 diabetes
Research demonstrates that it upregulates growth hormone receptor expression in tendon fibroblasts, facilitates angiogenesis via VEGFR2 signalling, stimulates collagen synthesis, and modulates nitric oxide production
BPC-157 demonstrates systemic effects even from gastric administration in some models, but localized vascular repair often requires direct proximity to the injury site